Usefulness of New Neutrophil-Related Hematologic Parameters in Patients with Myelodysplastic Syndrome

Usefulness of New Neutrophil-Related Hematologic Parameters in Patients with Myelodysplastic Syndrome

Myelodysplastic syndromes (MDS) are common malignant disorders with a poor prognosis. It is necessary to search for new rapid diagnostic methods to detect MDS patients with cytogenetic changes. The aim of the study was to assess new hematological neutrophil- and monocyte- related parameters I then b...

Full description

Bibliographic Details
Main Authors:	Iwona Kwiecień, Elżbieta Rutkowska, Krzysztof Gawroński, Katarzyna Kulik, Alicja Dudzik, Agata Zakrzewska, Agata Raniszewska, Waldemar Sawicki, Piotr Rzepecki
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Cancers
Subjects:	myelodysplastic syndrome hematology analyzer neutrophil scattering items Sysmex cytogenetic changes neutrophil parameters
Online Access:	https://www.mdpi.com/2072-6694/15/9/2488

Similar Items

PB1995: THE USEFULNESS OF NEUTROPHIL NEW PARAMETERS ASSESSMENTS AS AN ELEMENT TO DISTINGUISH PATIENTS WITH GENETIC CHANGES IN MYELODYSPLASTIC SYNDROME - A PRELIMINARY STUDY
by: Katarzyna Kulik, et al.
Published: (2023-08-01)

PB1991: NEW MONOCYTE HEMATOLOGICAL PARAMETERS AS AN IMPORTANT INDICATOR OF MDS PATIENTS WITH POSITIVE OGATA SCORE - A PRELIMINARY STUDY
by: Alicja Dudzik, et al.
Published: (2023-08-01)

Neutrophil Maturation, Reactivity and Granularity Research Parameters to Characterize and Differentiate Convalescent Patients from Active SARS-CoV-2 Infection
by: Iwona Kwiecień, et al.
Published: (2021-09-01)

PB1994: COMPARISON OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH HIGH AND LOW OGATA SCORE VALUES ON CYTOMETRY IN RELATION TO THE PRESENCE OF CYTOGENETIC ABNORMALITIES - A PRELIMINARY STUDY
by: Krzysztof Gawronski, et al.
Published: (2023-08-01)

Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation
by: Peter A. DeRosa, et al.
Published: (2022-06-01)

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype
by: Mar Mallo, et al.
Published: (2023-05-01)

Myelodysplastic Syndrome: Diagnosis and Screening
by: Francisco P. Tria, et al.
Published: (2022-06-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Hematologic malignancies : myelodysplastic syndromes /
by: Deeg, H. Joachim (Hans Joachim), 1945-
Published: (2006)

Automated Detection of Dysplasia: Data Mining from Our Hematology Analyzers
by: Jaja Zhu, et al.
Published: (2022-06-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
by: Minh Phuong Vu, et al.
Published: (2022-01-01)

The der(1;7)(q10;p10) defining a distinct profile from −7/del(7q) in myelodysplastic syndromes: A systematic review and meta‐analysis
by: Wei Lang, et al.
Published: (2024-01-01)

Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
by: Cătălina Roxana Ferea, et al.
Published: (2023-03-01)

Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment
by: Fabiana Kalina Marques, et al.
Published: (2022-12-01)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
by: Rafia Mahmood, et al.
Published: (2018-05-01)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
by: Yan Jiang, et al.
Published: (2021-01-01)

Rapid Detection of <i>Plasmodium vivax</i> by the Hematology Analyzer for Population Screening
by: Shanaz Khodaiji, et al.
Published: (2023-11-01)

A case of unilateral neutrophilic dermatosis of the dorsal hands
by: Ana G. Lopes, et al.
Published: (2023-04-01)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
by: R.F. Pinheiro, et al.
Published: (2008-07-01)

Distinct Clinical and Prognostic Features of Myelodysplastic Syndrome in Patients from the Middle East, North Africa, and Beyond: A Systemic Review
by: Amal Al-Haidose, et al.
Published: (2023-04-01)

Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry
by: Itay Barnea, et al.
Published: (2024-03-01)

A Novel Constitutional t(3;8)(p26;q21) and <i>ANKRD26</i> and <i>SRP72</i> Variants in a Child with Myelodysplastic Neoplasm: Clinical Implications
by: Viviane Lamim Lovatel, et al.
Published: (2023-04-01)

Hematological Manifestations of COVID-19 and its correlation with outcome – A retrospective study
by: Bobby Abraham, et al.
Published: (2021-01-01)

Hematological Parameters for Predicting Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Rohan Karkra, et al.
Published: (2023-06-01)

Role of hematological indices as predictors of systemic inflammation in dermatology
by: Sanmitra Aiholli, et al.
Published: (2024-01-01)

Cytogenetic abnormalities in patients with hematological malignancies in Lahore city, Pakistan
by: U. A. Awan, et al.
Published: (2021-10-01)

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
by: Pamela Acha, et al.
Published: (2022-11-01)

Can Automated Hematology Analyzers Predict the Presence of a Genetic Hemoglobinopathy? An Analysis of Hematological Biomarkers in Cambodian Women
by: Lulu X. Pei, et al.
Published: (2021-02-01)

Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine
by: Eri Takada, et al.
Published: (2024-02-01)

Role of reactive oxygen species in myelodysplastic syndromes
by: Qiangan Jing, et al.
Published: (2024-04-01)

Targeting neutrophil extracellular traps: A novel strategy in hematologic malignancies
by: Rongxing Liu, et al.
Published: (2024-04-01)

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA
by: Nicoletta Coccaro, et al.
Published: (2023-05-01)

Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes
by: Yao Qin, et al.
Published: (2022-12-01)

3D Telomere Structure Analysis to Detect Genomic Instability and Cytogenetic Evolution in Myelodysplastic Syndromes
by: Aline Rangel-Pozzo, et al.
Published: (2019-04-01)

Analysis of chromosomal abnormalities in patients with hematological malignancies in Isfahan population
by: Hamid Ganji, et al.
Published: (2017-05-01)

Long-term hematologic response after azacitidine treatment in a lower-risk myelodysplastic syndrome patient: A case report
by: Konstantinos Loukidis, et al.
Published: (2024-01-01)

Painful Erythematous Plaques on the Hands: A Quiz
by: Anna Ochi, et al.
Published: (2023-07-01)

Cow, Sheep and Goat Hematological Parameters: Comparative Studies Between Automated Analyzer and Manual Methods
by: Ibraheem E. Ibrhim
Published: (2014-12-01)

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study
by: Emma Bergfelt Lennmyr, et al.
Published: (2021-11-01)